These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

132 related articles for article (PubMed ID: 18700961)

  • 1. Cost effectiveness of chest pain unit care in the NHS.
    Oluboyede Y; Goodacre S; Wailoo A;
    BMC Health Serv Res; 2008 Aug; 8():174. PubMed ID: 18700961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Is a chest pain observation unit likely to be cost saving in a British hospital?
    Goodacre S; Morris F; Arnold J; Angelini K
    Emerg Med J; 2001 Jan; 18(1):11-4. PubMed ID: 11310454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomised controlled trial and economic evaluation of a chest pain observation unit compared with routine care.
    Goodacre S; Nicholl J; Dixon S; Cross E; Angelini K; Arnold J; Revill S; Locker T; Capewell SJ; Quinney D; Campbell S; Morris F
    BMJ; 2004 Jan; 328(7434):254. PubMed ID: 14724129
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of point-of-care biomarker assessment for suspected myocardial infarction: the randomized assessment of treatment using panel Assay of cardiac markers (RATPAC) trial.
    Fitzgerald P; Goodacre SW; Cross E; Dixon S
    Acad Emerg Med; 2011 May; 18(5):488-95. PubMed ID: 21569168
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Is a chest pain observation unit likely to be cost effective at my hospital? Extrapolation of data from a randomised controlled trial.
    Goodacre S; Dixon S
    Emerg Med J; 2005 Jun; 22(6):418-22. PubMed ID: 15911949
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient satisfaction with chest pain unit care: findings from the Effectiveness and Safety of Chest Pain Assessment to Prevent Emergency Admissions (ESCAPE) cluster randomised trial.
    Cross E; Goodacre S;
    Emerg Med J; 2010 Oct; 27(10):774-8. PubMed ID: 20659879
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A systematic review of the clinical effectiveness and cost-effectiveness of enzyme replacement therapies for Fabry's disease and mucopolysaccharidosis type 1.
    Connock M; Juarez-Garcia A; Frew E; Mans A; Dretzke J; Fry-Smith A; Moore D
    Health Technol Assess; 2006 Jun; 10(20):iii-iv, ix-113. PubMed ID: 16729919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of the clinical effectiveness and cost-effectiveness and economic modelling of minimal incision total hip replacement approaches in the management of arthritic disease of the hip.
    de Verteuil R; Imamura M; Zhu S; Glazener C; Fraser C; Munro N; Hutchison J; Grant A; Coyle D; Coyle K; Vale L
    Health Technol Assess; 2008 Jun; 12(26):iii-iv, ix-223. PubMed ID: 18513467
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cost-effectiveness of testing for hepatitis C in former injecting drug users.
    Castelnuovo E; Thompson-Coon J; Pitt M; Cramp M; Siebert U; Price A; Stein K
    Health Technol Assess; 2006 Sep; 10(32):iii-iv, ix-xii, 1-93. PubMed ID: 16948891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost effectiveness of diagnostic strategies for patients with acute, undifferentiated chest pain.
    Goodacre S; Calvert N
    Emerg Med J; 2003 Sep; 20(5):429-33. PubMed ID: 12954681
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation.
    Garside R; Pitt M; Anderson R; Rogers G; Dyer M; Mealing S; Somerville M; Price A; Stein K
    Health Technol Assess; 2007 Nov; 11(45):iii-iv, ix-221. PubMed ID: 17999840
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A systematic review and economic evaluation of the clinical effectiveness and cost-effectiveness of aldosterone antagonists for postmyocardial infarction heart failure.
    McKenna C; Burch J; Suekarran S; Walker S; Bakhai A; Witte K; Harden M; Wright K; Woolacott N; Lorgelly P; Fenwick L; Palmer S
    Health Technol Assess; 2010 May; 14(24):1-162. PubMed ID: 20492762
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sixty-four-slice computed tomography of the coronary arteries: cost-effectiveness analysis of patients presenting to the emergency department with low-risk chest pain.
    Khare RK; Courtney DM; Powell ES; Venkatesh AK; Lee TA
    Acad Emerg Med; 2008 Jul; 15(7):623-32. PubMed ID: 19086322
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-utility analysis of physiotherapy treatment compared with physiotherapy advice in low back pain.
    Rivero-Arias O; Gray A; Frost H; Lamb SE; Stewart-Brown S
    Spine (Phila Pa 1976); 2006 May; 31(12):1381-7. PubMed ID: 16721304
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adefovir dipivoxil and pegylated interferon alfa-2a for the treatment of chronic hepatitis B: a systematic review and economic evaluation.
    Shepherd J; Jones J; Takeda A; Davidson P; Price A
    Health Technol Assess; 2006 Aug; 10(28):iii-iv, xi-xiv, 1-183. PubMed ID: 16904047
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Systematic review and cost-effectiveness evaluation of 'pill-in-the-pocket' strategy for paroxysmal atrial fibrillation compared to episodic in-hospital treatment or continuous antiarrhythmic drug therapy.
    Saborido CM; Hockenhull J; Bagust A; Boland A; Dickson R; Todd D
    Health Technol Assess; 2010 Jun; 14(31):iii-iv, 1-75. PubMed ID: 20569652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of alternative strategies for the initial medical management of non-ST elevation acute coronary syndrome: systematic review and decision-analytical modelling.
    Robinson M; Palmer S; Sculpher M; Philips Z; Ginnelly L; Bowens A; Golder S; Alfakih K; Bakhai A; Packham C; Cooper N; Abrams K; Eastwood A; Pearman A; Flather M; Gray D; Hall A
    Health Technol Assess; 2005 Jul; 9(27):iii-iv, ix-xi, 1-158. PubMed ID: 16022802
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Laparoscopic surgery for inguinal hernia repair: systematic review of effectiveness and economic evaluation.
    McCormack K; Wake B; Perez J; Fraser C; Cook J; McIntosh E; Vale L; Grant A
    Health Technol Assess; 2005 Apr; 9(14):1-203, iii-iv. PubMed ID: 15842951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The clinical and cost-effectiveness of donepezil, rivastigmine, galantamine and memantine for Alzheimer's disease.
    Loveman E; Green C; Kirby J; Takeda A; Picot J; Payne E; Clegg A
    Health Technol Assess; 2006 Jan; 10(1):iii-iv, ix-xi, 1-160. PubMed ID: 16409879
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Topotecan, pegylated liposomal doxorubicin hydrochloride and paclitaxel for second-line or subsequent treatment of advanced ovarian cancer: a systematic review and economic evaluation.
    Main C; Bojke L; Griffin S; Norman G; Barbieri M; Mather L; Stark D; Palmer S; Riemsma R
    Health Technol Assess; 2006 Mar; 10(9):1-132. iii-iv. PubMed ID: 16545208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.